Much is known about the molecular and cell biological mechanisms underlying the pathophysiology of many monogenetic and acquired (multifactorial) disorders like type 2 diabetes, metabolic syndrome or cardiovascular diseases. In the last decade however it has become clear that disturbed metabolism of a variety of small molecules is either closely associated with the cause and onset of these diseases or with its progression. In addition disturbed metabolism plays a role in the progression of many other diseases like cancer and various types of neurodegenerative disorders like Parkinson. In this course the impact of disturbed metabolism on onset and progression of these diseases, the subject of the rapidly emerging field of Metabolomics, will be highlighted in a series of lectures discussing important disease examples.
Prof R Berger
Students of Bio-Pharmaceutical Sciences.
Will be announced during the course.
Minimum of 5 students
The course is usually taught in December
For information contact Prof R Berger (email@example.com).
Application via uSis.